Is Bioventus Inc. (BVS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 59.6% / 30% | 7.4% / 30% | 22.6% / 30% | 6.35% / 5% | ✗ NOT HALAL |
| DJIM | 59.6% / 33% | 7.4% / 33% | 22.6% / 33% | 6.35% / 5% | ✗ NOT HALAL |
| MSCI | 46.1% / 33% | 5.7% / 33% | 17.5% / 33% | 6.35% / 5% | ✗ NOT HALAL |
| S&P | 59.6% / 33% | 7.4% / 33% | 22.6% / 33% | 6.35% / 5% | ✗ NOT HALAL |
| FTSE | 46.1% / 33% | 5.7% / 33% | 17.5% / 50% | 6.35% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 68.3% | |
| Operating Margin | 13.8% | |
| Net Margin | 4.0% | |
| Return on Equity (ROE) | 13.2% | |
| Return on Assets (ROA) | 5.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $75M |
| Free Cash Flow | $72M |
| Total Debt | $294M |
| Debt-to-Equity | 136.3 |
| Current Ratio | 1.7 |
| Total Assets | $684M |
Price & Trading
| Last Close | $9.26 |
| 50-Day MA | $8.48 |
| 200-Day MA | $7.42 |
| Avg Volume | 312K |
| Beta | 0.7 |
|
52-Week Range
$5.81
| |
About Bioventus Inc. (BVS)
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company's restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Bioventus Inc. (BVS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Bioventus Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Bioventus Inc.'s debt ratio?
Bioventus Inc.'s debt ratio is 59.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 46.1%.
What are Bioventus Inc.'s key financial metrics?
Bioventus Inc. has a market capitalization of $602M, trailing P/E ratio of 27.1, and revenue of $568M. The company maintains a gross margin of 68.3% and a net margin of 4.0%. Return on equity stands at 13.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.